FDA.reportPublic FDA data

Staphysagria 200C

Manufacturer
Paramesh Banerji Life Sciences LLC
Effective date
2015-06-30
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:07:58

Label at a glance#

ProductStaphysagria 200C
Active ingredientDELPHINIUM STAPHISAGRIA SEED
Label structure9 sections

Indications and uses

Heals postoperative wounds, recurrent stye

Label contents#

Full prescribing information#

DRUG FACTS: Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Staphysagria 200C HPUS

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Sucrose, Lactose

Purpose

OTC - PURPOSE SECTION

Heals postoperative wounds, recurrent stye

Uses

INDICATIONS & USAGE SECTION

Heals postoperative wounds, recurrent stye

Warnings

WARNINGS SECTION

If pregnant or breast feeding ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Direction

DOSAGE & ADMINISTRATION SECTION

Adult or child: Take three pills daily. Leaving a gap of 30 minutes after any food or as advised by your physician.

Manufactured by

SPL UNCLASSIFIED SECTION

Paramesh Banerji Life Sciences, LLC.

North Brunswick, NJ 08902, USA.

Tel: +1-732-743-5936,

Email: info@pblifesciences.com

www.pblifesciences.com/permapotent

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Staphysagria 200CStaphysagria 200C

NDC: 69152-1193-1

Staphysagria 200C

Homeopathic Medicine

Heals postoperative wounds, recurrent stye

96 Pills (Approx.)

Product of USA

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69152-1193-12020-01-31C16284748780-19d75b9d0-6d39-f424-e053-dadaa90a57ce19b77de4-55b7-438b-e054-00144ff8d46c

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69152-1193-1Staphysagria 200C96 in 1 BOTTLEPELLET961

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69152-1193STAPHYSAGRIA 200C (STAPHYSAGRIA) PELLET [PARAMESH BANERJI LIFE SCIENCES LLC]1Legacy NDC, 1 package rows20160608_19b77de4-55b7-438b-e054-00144ff8d46c.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69152-119369152-1193-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
DELPHINIUM STAPHISAGRIA SEED00543AP1JVACTIB
SUCROSEC151H8M554IACT
LACTOSEJ2B2A4N98GIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
19b77de4-55b8-438b-e054-00144ff8d46c19b77de4-55b7-438b-e054-00144ff8d46c2015-06-30WarningsExact identifier
spl id: 19b77de4-55b8-438b-e054-00144ff8d46c
spl set id: 19b77de4-55b7-438b-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.